Covid-19 Testing for K-8 Schools, Underserved Communities, and Congregate Settings





COVID-19 testing has been limited by a global shortage of critical supplies(1). PerkinElmer is extending support to mitigate the issue by providing a live stream of RT-PCR test and automated RNA extraction equipment lead time for setting up labs to process 50,000 samples each day. The lead time will be updated regularly based on inventory and demand.

Contact Us To Overcome Your SARS-CoV-2 Challenges


We are here to help laboratories overcome their SARS-CoV-2 testing challenges so they can better address the world’s urgent public health concerns. We are working closely with laboratories around the world to deliver the nucleic acid isolation, automation, real-time PCR, antibody testing, and vaccine development solutions they need to rapidly respond to these challenges. Our top priority is to provide the technology and support to meet these needs.

We help labs:

  • Increase throughput
  • Improve accuracy
  • Increase efficiency
  • Enhance laboratory safety

Protect Your Lab from SARS-CoV-2 Testing Supply Chain Interruptions

Supply chain interruptions can have a significant impact on a lab’s SARS-CoV-2 testing capacity, delaying, decreasing, or even preventing a lab’s ability to perform testing. If your testing has been disrupted due to your inability to obtain needed resources, a shift in testing methodology can give you the flexibility you need to better react to the world’s rapidly changing needs.

To address growing supply constraints worldwide, PerkinElmer has expanded the production capacity of our coronavirus workflow components including reagents, instruments, and consumables. We have the capability to ship millions of our extraction and RT-PCR tests to our customers. In addition, PerkinElmer is one of the few companies with single-source SARS-CoV-2 workflows giving customers the ability to order all of the components from one source.

You Are Not Alone

PerkinElmer is a supplier you can depend on to eliminate your supply chain nightmares. We are there for you. SARS-CoV-2 testing technical support experts are available day and night by email to ensure you get the help you need, when you need it.


Fast & Sensitive Antigen Test – CE-IVD
Enable your POC testing with the PerkinElmer COVID-19 Antigen Test, a simple, rapid, and reliable lateral flow immunoassay test used to screen or diagnose COVID-19 in asymptomatic or symptomatic individuals.


PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel 1 – EUA
The FDA EUA authorized PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel 1 is a real-time RT-PCR multiplexed test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and RSV.

K-12 Testing
With a sensitive, FDA EUA RT-PCR COVID-19 assay to screen pooled, asymptomatic individuals, your lab can affordably screen K-12 students.

COVID-19 Passport
Give your customers confidence your institution is safe with a COVID-19 passport. Learn how to implement your passport to the new normal.

Simultaneous COVID-19, Flu, and RSV Test – CE-IVD
Detect and differentiate SARS-CoV-2, influenza A, influenza B, and RSV in a single sample with the CE-IVD marked PKamp Respiratory SARS-CoV-2 RT-PCR Panel. This workflow enables labs to conserve resources while testing a single sample for multiple pathogens.

PerkinElmer® New Coronavirus Nucleic Acid Detection Kit Authorized Under FDA EUA
The PerkinElmer® New Coronavirus Nucleic Acid Detection Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in human oropharyngeal, nasopharyngeal, and anterior nasal swab samples. This kit may be used to test either symptomatic or asymptomatic individuals. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests, or by similarly qualified non-U.S. laboratories.

PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay CE-IVD

Pool your SARS-CoV-2 samples from asymptomatic or symptomatic patients with the CE-IVD marked PerkinElmer® SARS-CoV-2 Real-time RT-PCR assay. Saliva samples are also supported in addition to swabs.

COVID-19 Lab-In-A-Lab™ Testing Solution
Increase your SARS-CoV-2 testing capabilities with the COVID-19 Lab-In-A-Lab™ testing solution, a full-service turnkey testing option embedded in your CLIA certified lab.



PerkinElmer® SARS-CoV-2 Nucleic Acid Detection Kit (RUO)
Designed to streamline SARS-CoV-2 laboratory developed testing, the PerkinElmer SARS-CoV-2 Nucleic Acid Detection Kit (RUO) is an real-time RT-PCR-based assay.

Viral RNA Isolation
The PerkinElmer chemagic Viral DNA/ RNA 300 Kit H96 and the chemagic 360 instrument deliver fast, high throughput extraction of high-quality RNA for use with PCR-based detection of SARS-CoV-2. With this setup, RNA can be extracted from 96 samples per hour, producing high quality RNA.

Automation of RNA Isolation Setup and PCR Assay Setup
Specialized JANUS® G3 automated workstations are now available to optimize your SARS-CoV-2 testing workflow. With the ability to automate sample prep for RNA isolation and PCR setup these workstations are designed to be used with any SARS-CoV-2 viral extraction and detection assay chemistry.

Mobile Monitoring of SARS-CoV-2 Testing
PerkinElmer has coupled the new PKeye™ Mobile Operations Monitor with the JANUS® G3 Primary Sample reformatter and PCR liquid handler to enable your lab to increase the consistency and reliability of your automated SARS-CoV-2 detection workflow.

explorer™ Workstations for End-to-End SARS-CoV-2 Testing
PerkinElmer enables labs to maximize the efficiency of their SARS-CoV-2 RT-PCR and ELISA testing with scalable and modular explorer workstations and a reliable supply of reagents and consumables, ensuring they can meet their ever-changing testing needs.

BeadBoost Bead Mill Homogenizer
By homogenizing saliva samples prior to processing with the BeadBoost Bead Mill homogenizer you can increase the sensitivity and ease of processing of SARS-CoV-2 testing from saliva samples.

Flexible Solutions for Detection of SARS-CoV-2 Mutations
Identify SARS-CoV-2 variants with either a fast, RT-PCR workflow to detect mutations in specific variants or an unbiased NGS workflow delivering a genome-wide solution. PerkinElmer’s second-tier assays give labs the flexibility to implement a solution based on the information being sought and workflow considerations.

NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit
The NEXTFLEX® Variant-Seq™ SARS-CoV-2 kit has optimized the identification and tracking of SARS-CoV-2 variants by quickly, easily, and affordably identifying all mutations in a SARS-CoV-2 sample using amplicon sequencing. Sample preparation has been simplified, throughput has been increased, and multiple automation solutions offer flexibility based on your lab’s needs.

PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR assays
The PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR assays utilize real-time RT-PCR multiplexing technology for simultaneous qualitative detection and differentiation of several known SARS-CoV-2 mutations.

Overview of SARS-CoV-2 Antibody Assays
Explore PerkinElmer’s immunoassays optimized for use with varied samples types, throughputs, run times, and targets.

PerkinElmer® GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit CE-IVD
The PerkinElmer® GSP®/DELFIA® Anti-SARS-CoV-2 IgG kit delivers qualitative detection of human IgG antibodies against SARS-CoV-2 in dried blood spots, plasma, and serum to identify individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

PerkinElmer® SuperFlex™ Anti-SARS-CoV-2 IgG Kit CE-IVD
Achieve fast, hands-free anti-SARS-CoV-2 IgG antibody detection using direct chemiluminescence technology with the SuperFlex™ Anti-SARS-CoV-2 kit. Samples are run on the SuperFlex™ Chemiluminescent Immunoassay system, allowing hands-free analysis of up to 48 samples per hour to quickly identify recent or prior infections.

SuperFlex™ Chemiluminescent Immunoassay System CE-IVD
The SuperFlex™ Chemiluminescent Immunoassay system delivers fast, hands-free analysis of small biological molecules using labeled antibodies and antigens.

SARS-CoV-2 ELISA Test Systems from EUROIMMUN

Simplifying the Analysis of the SARS-CoV-2 Virus with NGS
PerkinElmer’s NGS workflows enable effective and high-throughput detection of the SARS-CoV-2 virus, surveillance and epidemiological studies, the tracking of mutational changes in the virus, unbiased pathogen discovery, and the analysis of potential susceptibility and human response to SARS-CoV-2 infection.


Improve the Productivity of Real-time SARS-CoV-2 RT-PCR Testing Workflow

sars-cov-2 workflow

SARS-CoV-2 Testing Saliva Workflow
Optimize your workflow for SARS-CoV-2 testing of saliva samples to simplify sample processing and increase your testing sensitivity.

Biosurveillance of Wastewater for Coronavirus Workflows

Speed Up Your Nucleic Acid and Protein Analysis for SARS-CoV-2 Vaccine Development

SARS-CoV-2 Surface Testing
Streamline your surface testing of SARS-Cov-2 with an automated workflow using proven and sensitive PerkinElmer technology.


Real-time PCR Assay Antibody Assay Targeted Sequencing WGS/Shotgun Sequencing Expression Analysis
Detect active infections X
Detect virus X X X
Perform surveillance & epidemiology X X X
Detect patient immunity X
Speed & TAT X X
Track mutations X X
Discovery X X
Analyze human response to disease X X X


SARS-CoV-2 Testing in California

Governor Newsom Announces Major Plan to More than Double State’s Testing Capacity, Reduce Turnaround Time

SARS-CoV-2 Testing in Wales

Over 200 Jobs Announced as Part of the Welsh Lighthouse Lab Facility


Why PerkinElmer Chose TopDutch to Produce Millions of Corona Tests


‘It’s The Hunger Games for Laboratories.’ Why Some People Are Waiting Weeks for Their COVID-19 Test Results


Scaling up RT-PCR Assays for Mass Population Screening in the Fight Against COVID-19

Sonoma County Aims to Triple Volume of Coronavirus Test Processing with New Technology

Read how FioCruiz increased their SARS-CoV-2 testing

Fiocruz implanta Unidades de Apoio ao Diagnóstico da Covid-19

Read how Texas boosted its COVID-19 testing capacity

Texas Works with ESG-friendly Testing Company PerkinElmer to Tame Pandemic

Rutgers is leveraging the explorer™ G3 workstation for SARS-CoV-2 testing of saliva samples

New Coronavirus Test Developed at Rutgers can Screen Thousands & It’s as Simple as a Spit in a Tube


Global Collaboration Establishes Wales’ National Covid-19 Testing Laboratory


Sema4 to Deliver High Capacity COVID-19 Testing in Partnership with the State of Connecticut



PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel

Welsh Lighthouse Laboratory Extends Contract with PerkinElmer for its COVID-19 Solutions

PerkinElmer Changes COVID-19 Rapid Testing Landscape with Highly Sensitive Point of Care Antigen Test for Mass Screening

PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing

EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response

EUROIMMUN Launches Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected Patients

EUROIMMUN Receives CE Mark for New PCR Test to Differentiate Between COVID-19 and Flu

Charnwood Lighthouse Lab Goes Live Processing Thousands of COVID-19 Tests per Day with PerkinElmer Solutions

PerkinElmer SARS-CoV-2 RT-PCR Assay Receives CE Mark for Saliva and Sample Pooling to Test Symptomatic and Asymptomatic Individuals

EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein

PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19

PerkinElmer Launches Online, Open Access COVID-19 Data Dashboards to Accelerate Antiviral Therapeutics Research

PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization for Sample Pooling

PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19

PerkinElmer Launches Online, Open Access COVID-19 Data Dashboards to Accelerate Antiviral Therapeutics Research

PerkinElmer Launches Modular and Scalable explorer™ Workstations for High-throughput COVID-19 Detection

PerkinElmer Launches Online, Open Access COVID-19 Data Dashboards to Accelerate Antiviral Therapeutics Research

PerkinElmer Releases New Dried Blood Spot Based COVID-19 Serology Test

Sonora Quest Collaborates with State and Health Care Leaders to Vastly Expand COVID-19 Testing Capacity in Arizona

Global Collaboration Establishes Wales’ National Covid-19 Testing Laboratory

FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies

EUROIMMUN is one of first European manufacturers of diagnostic tests to provide CE-marked antibody detection systems to support COVID-19 diagnostics

FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing



  1. COVID-19 Survey report, June 11, 2020 (https://educate.amp.org/local/catalog/view/product.php?productid=186)
Contact Us To Overcome Your SARS-CoV-2 Challenges